Relapse-free cure from multidrug-resistant tuberculosis in Germany

Funding

Conflict of interest: J. Heyckendorf has received personal fees for lecturing at sponsored symposia from Chiesi, Gilead, Janssen and Lucane, outside the submitted work. B. Kalsdorf has provided independebt lectures for Lucane Pharma and Oxford Immunotec, outside the submitted work. H.J.F. Salzer has received honoraria for talks at scientific symposia organised by Chiesi and research grants from Gilead, outside the submitted work. C. Lange has received personal fees for lecturing at sponsored symposia from Chiesi, Gilead, Abbvie, MSD, Becton Dickinson, Janssen, Lucane, Novartis and Thermofisher, outside the submitted work. Support statement: The study was funded by the German Center for Infection Research (DZIF). Funding information for this article has been deposited with the Crossref Funder Registry.